Mydecine Innovations Group Inc - ESG Rating & Company Profile powered by AI
The article contains a questions and answers table for Mydecine Innovations Group Inc. Check the end of the webpage for potential risks for Mydecine Innovations Group Inc based on industry, location and marketcap. This ESG assessment for Mydecine Innovations Group Inc indicates the company's transparency towards the United Nations Sustainable Development Goals.
Mydecine Innovations Group Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.4; made up of an environmental score of 2.7, social score of 1.6 and governance score of 0.0.
1.4
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1715 | Polaris Group | 1.6 | Low |
1715 | RenovaCare Inc | 1.6 | Low |
1747 | Mydecine Innovations Group Inc | 1.4 | Low |
1747 | Chembio Diagnostics Inc | 1.4 | Low |
1747 | Pharmaron Beijing Co Ltd | 1.4 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Mydecine Innovations Group Inc have an accelerator or VC vehicle to help deliver innovation?
Does Mydecine Innovations Group Inc disclose current and historical energy intensity?
Does Mydecine Innovations Group Inc report the average age of the workforce?
Does Mydecine Innovations Group Inc reference operational or capital allocation in relation to climate change?
Does Mydecine Innovations Group Inc disclose its ethnicity pay gap?
Does Mydecine Innovations Group Inc disclose cybersecurity risks?
Does Mydecine Innovations Group Inc offer flexible work?
Does Mydecine Innovations Group Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Mydecine Innovations Group Inc disclose the number of employees in R&D functions?
Does Mydecine Innovations Group Inc conduct supply chain audits?
Does Mydecine Innovations Group Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Mydecine Innovations Group Inc conduct 360 degree staff reviews?
Does Mydecine Innovations Group Inc disclose the individual responsible for D&I?
Does Mydecine Innovations Group Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Mydecine Innovations Group Inc disclose current and / or historical scope 2 emissions?
Does Mydecine Innovations Group Inc disclose water use targets?
Does Mydecine Innovations Group Inc have careers partnerships with academic institutions?
Did Mydecine Innovations Group Inc have a product recall in the last two years?
Does Mydecine Innovations Group Inc disclose incidents of discrimination?
Does Mydecine Innovations Group Inc allow for Work Councils/Collective Agreements to be formed?
Has Mydecine Innovations Group Inc issued a profit warning in the past 24 months?
Does Mydecine Innovations Group Inc disclose parental leave metrics?
Does Mydecine Innovations Group Inc disclose climate scenario or pathway analysis?
Does Mydecine Innovations Group Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Mydecine Innovations Group Inc disclose the pay ratio of women to men?
Does Mydecine Innovations Group Inc support suppliers with sustainability related research and development?
Does Mydecine Innovations Group Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Mydecine Innovations Group Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Mydecine Innovations Group Inc involved in embryonic stem cell research?
Does Mydecine Innovations Group Inc disclose GHG and Air Emissions intensity?
Does Mydecine Innovations Group Inc disclose its waste policy?
Does Mydecine Innovations Group Inc report according to TCFD requirements?
Does Mydecine Innovations Group Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Mydecine Innovations Group Inc disclose energy use targets?
Does Mydecine Innovations Group Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Mydecine Innovations Group Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Mydecine Innovations Group Inc
These potential risks are based on the size, segment and geographies of the company.
Mydecine Innovations Group Inc., a biotech and life sciences company, engages in the development and commercialization of drugs for treating mental health problems. It develops therapies for veterans, emergency medical service providers, post-traumatic stress disorder, and front-line workers; and operates Mindleap, a digital telehealth platform that provides access to mental health services, as well as psychedelic integration services, including psychedelic aftercare and wellness services. The company also engages in the drug discovery and builds nature-sourced psychedelic-assisted therapeutics, compounds, therapy protocols, and unique delivery systems. In addition, it operates hemp farm in Pottus, Texas. Mydecine Innovations Group Inc. has a partnership with Leiden University Medical Center; Royal Ottawa Mental Health Centre; LeadGen Labs to support psychedelic drug development; and Applied Pharmaceutical Innovation for drug development and clinical trial programs. The company was formerly known as NewLeaf Brands Inc. and changed its name to Mydecine Innovations Group Inc. in June 2020. Mydecine Innovations Group Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.